Answers are grounded in this paper and cite their sources.
Background: Cardiovascular risk factors accumulate during young adulthood, yet body mass index (BMI) remains the default screening index even though it cannot separate fat from lean tissue. Somatotype, which describes physique through three components (endomorphy, mesomorphy, ectomorphy), and direct body-composition measures could refine risk description in healthy young men, but the relevant literature is fragmented: studies usually examine physique or body composition on one side and cardiovascular function on the other. Objective: To synthesise evidence linking somatotype, body composition and cardiovascular functional indicators (blood pressure, heart rate and heart rate variability, arterial stiffness, and cardiorespiratory fitness) in healthy young men, to ask whether somatotype adds information beyond BMI, and to identify and prioritise research gaps. Methods: Narrative review guided by the SANRA criteria. Primary studies, systematic reviews, consensus documents and foundational texts on somatotyping, adiposity assessment, and cardiovascular function were collected and appraised for design, measurement methods and population. Findings: Somatotype components track body composition in expected directions, with endomorphy reflecting fatness and mesomorphy reflecting lean robustness. Observational studies in adults and young adults relate endomorphy to less favourable blood pressure, autonomic profile and aerobic fitness, and mesomorphy to higher aerobic capacity; effects are often modest and based on small cross-sectional samples. Studies of normal-weight obesity confirm that BMI misclassifies cardiometabolic risk. We found no study that formally tested the incremental value of somatotype over BMI, waist-to-height ratio or percentage body fat in healthy young men, none that combined somatotype, body composition and several cardiovascular domains in one cohort, and very little comparable data for South and Central Asian men. Twelve gaps are identified, spanning measurement standardisation, analytical handling of somatotype components, ancestry-specific evidence and longitudinal design. Conclusions: Somatotype is a plausible but unproven complement to BMI. A priority-ordered research agenda, built around multi-domain cardiovascular phenotyping, standardised protocols and explicit incremental-value testing, is proposed.
No takes yet. Share an insight, caveat, or question.
Asanbekova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: